← Leaderboards
Martin Goulet
Harvard University (Medical School)
$470,618
Attributed
$470,618
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$470,618 · 4
By mechanism
P51$470,618 · 4
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Lewis A Lipsitz$26,291,680
- Clifford B Saper$31,019,645
- David A. Sinclair$25,944,681
- Roger D Spealman$14,290,245
- Martha Shenton$39,463,906
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingBehavioral /Social Science Research TagDrug Adverse EffectMammaliaNervous SystemPharmacologyPsychologyTechnology /Technique
Grant awards (6)
DEVELOPMENT OF MODEL OF MILD &ADVANCED PARKINSONISM IN NON HUMAN PRIMATES$111,112
P51 · FY2002 · RR
EFFICACY OF DOPAMINE D1 AGONIST DEPENDS ON SEVERITY OF PARKINSONISM$111,112
P51 · FY2002 · RR
DEVELOPMENT OF MODEL OF MILD &ADVANCED PARKINSONISM IN NON HUMAN PRIMATES$111,112
P51 · FY2001 · RR
EFFICACY OF DOPAMINE D1 AGONIST DEPENDS ON SEVERITY OF PARKINSONISM$111,112
P51 · FY2001 · RR
LONG TERM EFFECTS OF STIMULANT MEDICATIONS POSSIBLE RELEVANCE TO ADHD TREATMENT$13,085
P51 · FY2000 · RR
D1 AGONISTS ARE MORE EFFECTIVE IN ADVANCED THAN IN MILD PARKINSONISM$13,085
P51 · FY2000 · RR